Get your free personalized podcast brief
We scan new podcasts and send you the top 5 insights daily.
Instead of only selling to individual dental offices, Flossy leverages its deep relationships with private equity firms. By selling directly to the PE firms that own large dental service organizations (DSOs), they create an efficient top-down channel to sign deals covering hundreds of locations at once.
Related Insights
Polygraph AI bypassed traditional top-down sales by first engaging security engineers and compliance teams. By understanding their world and using a fast Proof-of-Concept (POC) to prove value, they created internal champions who drove the sale from the ground up, building trust through the product itself.
When direct-to-consumer growth flattens and acquisition costs rise, B2B channels offer a scalable alternative. Betterment's founder notes their B2B expansion not only provided scale but also fed more users back into their retail product, creating a powerful growth flywheel.
Contrary to popular belief, the primary buyers for mid-market B2B SaaS are not competitors (strategics) but private equity firms. They acquire companies as platforms or as "tuck-ins" to their existing portfolio companies, making them the most dominant force in this M&A landscape.
Contrary to the popular belief that strategic buyers dominate, 70% of B2B SaaS acquisitions between $2M and $20M ARR are made by private equity firms or their portfolio companies. This makes the market opaque for founders, who often receive bad advice and undervalue their businesses by not understanding the primary buyer class.
Partnering with Corporate Venture Capital (CVC) arms is a powerful, underutilized distribution strategy. By requiring CVCs to bring in a set amount of revenue alongside their investment, startups perfectly align incentives and gain an internal champion to navigate large enterprise accounts and close deals.
Flossy's AI receptionist beats general tools like Intercom by focusing on the dental industry's primary revenue-generating action: scheduling patients. While horizontal tools are built for conveying information, Flossy's value is in driving bookings, demonstrating a key vertical SaaS strategy of owning the customer's core workflow.
While conventional wisdom suggests moving upmarket for growth, Sensei chose the opposite path to scale from $40M to $100M ARR. They partnered with Pax8 to target a vast number of smaller customers downstream, leveraging the channel's reach for a "10x proposition" without the heavy investment required for enterprise sales readiness.
Traditionally, investment bankers ignored smaller SaaS deals. A market shift occurred when private equity funds began acquiring smaller companies (sub-$20M ARR). This created a need for specialized M&A advisory firms who understand this new universe of PE buyers and their specific deal structures.
Instead of marketing directly to a fragmented customer base (e.g., fitness coaches), sell your platform to the agencies and mentors who already serve them. This leverages their distribution, resulting in a stickier, more profitable customer base with a lower acquisition cost.
To break into slow-moving hospitals, Aegis initially targeted smaller, more agile medical billing companies that serve them. This strategy builds a proven product and case studies with customers who have a direct need and faster sales cycles, creating a powerful entry point to the larger hospital systems.
